Madrid 2017: Are you proactive about risk assessment?
Previous Post
Madrid 2017: Can MRD testing in trials guide decisions?
Next Post
Which new therapies will make an impact?
This webpage has been archived. The information provided here may be outdated. Looking for more updated and relevant content? Search the International Myeloma Foundation website for the latest and most relevant information.